The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy

5700 South Maryland Avenue
Chicago, Illinois 60637

We've found

1 trials

at this facility

Phase 1 Study Of PF-06863135, A BCMA- CD3 Bispecific Ab, In Relapse/ Refractory Multiple Myeloma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Chicago, IL

Use our guide to learn which trials are right for you!